Varde Partners Inc sold $13M of NBR
owner at NABORS INDUSTRIES LTD. 312,378 shares at an average of $41.04, traded Sep 11, 2025, filed Sep 15, 2025.
Score components
- +12Role10% owner
- +25Trade size$12.8M at market
- +5Share of holdings soldSold 18% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.0%, 3m +28.9%, 6m +83.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-203991, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | SOpen-market sale Common Sharesindirect: See footnotes | -305,000 | $41.01 | $13M | 1,413,430 | Sep 15, 2025 |
| Sep 11, 2025 | SOpen-market sale Common Sharesindirect: See footnotes | -7,378 | $42.33 | $312k | 1,406,052 | Sep 15, 2025 |
Related signals
Other insiders at NABORS INDUSTRIES LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 39Weak | NBRsell NABORS INDUSTRIES LTD | David J Tudor director | $295k 3,200 shares | -38% | |
| 39Weak | NBRbuy NABORS INDUSTRIES LTD | John Yearwood director | $501k 6,410 shares | +29% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.